Drug intelligence / Profile preview

Stem Cell Derived Exosome

Development stage
Preclinical
Lead developer
EHL Bio
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
Administration
Intravenous, Intranasal, Inhalation, Oral, Intraarticular, Intratumoral, Intraperitoneal, Subcutaneous, Topical, Ophthalmic, Intrathecal
01

Overview

Stem Cell Derived Exosome is an exosome-based therapy developed by EHL Bio, utilizing extracellular vesicles harvested from adipose-derived stem cells (ADSCs). These exosomes function by delivering a cargo of bioactive molecules—including proteins, lipids, and various RNA species—to target cells, thereby facilitating paracrine signaling. This mechanism is intended to promote tissue repair, regenerate cartilage, and modulate inflammatory pathways. The therapy is being investigated for a broad range of applications, including neuropathic pain, wound healing, hypertension, and neurodegenerative conditions such as Alzheimer's and Parkinson's disease. It is currently in the preclinical stage of development, specifically undergoing animal testing.

Other names
ADSC-derived exosomesEHL Bio-exosome therapy

Beyond the preview

Go deeper on Stem Cell Derived Exosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stem Cell Derived Exosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call